BR122020011626B8 - processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal - Google Patents

processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal

Info

Publication number
BR122020011626B8
BR122020011626B8 BR122020011626A BR122020011626A BR122020011626B8 BR 122020011626 B8 BR122020011626 B8 BR 122020011626B8 BR 122020011626 A BR122020011626 A BR 122020011626A BR 122020011626 A BR122020011626 A BR 122020011626A BR 122020011626 B8 BR122020011626 B8 BR 122020011626B8
Authority
BR
Brazil
Prior art keywords
salt
benzofuran
carboxamide
piperazinyl
indolyl
Prior art date
Application number
BR122020011626A
Other languages
English (en)
Other versions
BR122020011626B1 (pt
Inventor
Bathe Andreas
Original Assignee
Merck Patent Ges Mit Beschraenkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Ges Mit Beschraenkter Haftung filed Critical Merck Patent Ges Mit Beschraenkter Haftung
Publication of BR122020011626B1 publication Critical patent/BR122020011626B1/pt
Publication of BR122020011626B8 publication Critical patent/BR122020011626B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

a presente invenção refere-se a um processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxamida ou seu sal fisiologicamente aceitável compreendendo a etapa de reagir um composto de fórmula ii ii como base ou sal de hx (onde x = cl, br), com 3-(4-oxobutil)-1h-indol-5-carbonitrila por aminação redutiva.
BR122020011626A 2005-04-26 2006-04-12 processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal BR122020011626B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102005019670.5 2005-04-26
DE102005019670A DE102005019670A1 (de) 2005-04-26 2005-04-26 Verfahren zur Herstellung von (5-(4-[4-(5-Cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamid
PCT/EP2006/003344 WO2006114202A1 (de) 2005-04-26 2006-04-12 Verfahren zur herstellung von 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid
BRPI0610336A BRPI0610336B8 (pt) 2005-04-26 2006-04-12 processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável.

Publications (2)

Publication Number Publication Date
BR122020011626B1 BR122020011626B1 (pt) 2021-01-19
BR122020011626B8 true BR122020011626B8 (pt) 2021-07-27

Family

ID=36603535

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0610336A BRPI0610336B8 (pt) 2005-04-26 2006-04-12 processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável.
BR122020011626A BR122020011626B8 (pt) 2005-04-26 2006-04-12 processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0610336A BRPI0610336B8 (pt) 2005-04-26 2006-04-12 processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável.

Country Status (21)

Country Link
US (1) US7799916B2 (pt)
EP (1) EP1874762B1 (pt)
JP (2) JP5113039B2 (pt)
KR (1) KR101310191B1 (pt)
CN (1) CN101163698B (pt)
AT (1) ATE420875T1 (pt)
AU (1) AU2006239569B2 (pt)
BR (2) BRPI0610336B8 (pt)
CA (1) CA2605758A1 (pt)
CY (1) CY1108904T1 (pt)
DE (2) DE102005019670A1 (pt)
DK (1) DK1874762T3 (pt)
ES (1) ES2320172T3 (pt)
HK (1) HK1116492A1 (pt)
MX (1) MX2007013258A (pt)
PL (1) PL1874762T3 (pt)
PT (1) PT1874762E (pt)
RU (1) RU2397981C2 (pt)
SI (1) SI1874762T1 (pt)
WO (1) WO2006114202A1 (pt)
ZA (1) ZA200710145B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102267985B (zh) * 2011-06-15 2015-12-09 上海医药工业研究院 维拉佐酮或其盐酸盐的制备方法
CN102267932A (zh) * 2011-06-15 2011-12-07 上海医药工业研究院 4-(5-氰基-1h-吲哚-3-基)丁基取代磺酸酯类化合物及其应用
CN102949364A (zh) * 2011-08-30 2013-03-06 天津药物研究院 一种含有效成分盐酸维拉佐酮的缓释片
EP2809665A1 (en) * 2012-02-01 2014-12-10 Ranbaxy Laboratories Limited Process for the preparation of vilazodone or its pharmaceutically acceptable salts
WO2013168126A1 (en) 2012-05-11 2013-11-14 Dr.Reddys Laboratories Limited Crystalline forms of vilazodone hydrochloride and vilazodone free base
WO2013175361A1 (en) * 2012-05-24 2013-11-28 Ranbaxy Laboratories Limited Process for the preparation of vilazodone hydrochloride
CN102796037B (zh) * 2012-08-09 2013-11-06 成都苑东药业有限公司 一种3-(4-(4-取代哌嗪)-1-丁酰基)吲哚-5-甲腈及其用途
WO2014028473A1 (en) * 2012-08-13 2014-02-20 Assia Chemical Industries Ltd. New salts of vilazodone and solid state forms thereof
CN102875538A (zh) * 2012-10-16 2013-01-16 北京诚创思达医药科技有限公司 维拉唑酮或其盐酸盐的制备方法
WO2014061004A2 (en) * 2012-10-19 2014-04-24 Ranbaxy Laboratories Limited Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof
WO2014064715A2 (en) * 2012-10-22 2014-05-01 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for preparing thereof
WO2014199313A1 (en) 2013-06-12 2014-12-18 Lupin Limited Substantially pure vilazodone hydrochloride and a process thereof
CN105017233A (zh) * 2014-04-23 2015-11-04 天津药物研究院 一种盐酸维拉佐酮晶体、其制备方法、药物组合物和用途
CN103965148B (zh) * 2014-05-15 2016-04-06 北京北陆药业股份有限公司 一种5-(哌嗪-1-基)苯并呋喃-2-羧酸乙酯的合成方法
CN107501159B (zh) * 2017-08-14 2020-11-24 连云港恒运药业有限公司 维拉佐酮中间体3-(4-氯丁基)-5-氰基吲哚合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (de) 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19514567A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Benzofurane
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
DE10252102A1 (de) * 2002-11-08 2004-05-27 Merck Patent Gmbh Indolderivate

Also Published As

Publication number Publication date
DK1874762T3 (da) 2009-04-14
MX2007013258A (es) 2008-01-22
JP2012255005A (ja) 2012-12-27
SI1874762T1 (sl) 2009-04-30
WO2006114202A1 (de) 2006-11-02
JP5735465B2 (ja) 2015-06-17
JP2008539178A (ja) 2008-11-13
DE502006002659D1 (de) 2009-03-05
ATE420875T1 (de) 2009-01-15
US7799916B2 (en) 2010-09-21
AU2006239569B2 (en) 2012-04-12
BRPI0610336B1 (pt) 2020-09-24
HK1116492A1 (en) 2008-12-24
KR101310191B1 (ko) 2013-09-24
ES2320172T3 (es) 2009-05-19
BRPI0610336A2 (pt) 2010-06-15
ZA200710145B (en) 2008-11-26
CN101163698B (zh) 2011-05-18
CA2605758A1 (en) 2006-11-02
JP5113039B2 (ja) 2013-01-09
RU2397981C2 (ru) 2010-08-27
EP1874762B1 (de) 2009-01-14
BRPI0610336B8 (pt) 2021-05-25
US20080293943A1 (en) 2008-11-27
EP1874762A1 (de) 2008-01-09
AU2006239569A1 (en) 2006-11-02
CY1108904T1 (el) 2012-05-23
DE102005019670A1 (de) 2006-11-02
KR20080013920A (ko) 2008-02-13
BR122020011626B1 (pt) 2021-01-19
PT1874762E (pt) 2009-04-16
CN101163698A (zh) 2008-04-16
PL1874762T3 (pl) 2009-05-29
RU2007143504A (ru) 2009-06-10

Similar Documents

Publication Publication Date Title
BR122020011626B8 (pt) processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal
ATE530519T1 (de) Cyclobutylaminderivate
NO20075626L (no) Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
BRPI0519597A2 (pt) derivados de (3r, 6r)-3-(2, 3-diidro-1h-inden-2-il)-2, 5-piperazinadiona 1, 6-substituÍda como antagonistas de receptores de oxitocina para o tratamento de parto prematuro, dismenorrÉia e endometriose
CY1112483T1 (el) Αγωνιστες gpcr πιπεριδινης
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
BR112012012584A2 (pt) "processo para preparar sais de 4,5-diidroisoxazol-3-tiocarboxamidina 5,5-dissubstituídos de fórmula (i)"
NO20081905L (no) Benzotiazolcyklobutylaminderivater og deres anvendelse som histamin-3-reseptorligander
BRPI0517456A (pt) sìntese assimétrica de dihidrobenzofuranos substituìdos
ATE557024T1 (de) Piperidinverbindungen als gpcr-agonisten
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
NO20090173L (no) Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes
NO20080897L (no) Salter av 4-metyl-N-[3-(4-metylimidazol-1-yl)-5-trifluormetylfenyl]-3-(4-pyridin-3-ylpyrimidin-2-ylamino)benzamid
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
ATE557023T1 (de) Piperidinylverbindungen als gpcr-agonisten
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
BRPI0914772A2 (pt) compostos heterocíclicos 1,2-dissubstituídos
BR112014009717A8 (pt) derivados de 2-(fenil ou pirid-3-il)aminopirimidina como moduladores de cinase lrrk2 para o tratamento de doença de parkinson.
EA201170524A1 (ru) Урацилсодержащие соединения и гербициды, включающие такие соединения
NO20084583L (no) Makrosykliske kinase-inhibitorer
BRPI1014077A8 (pt) Derivados de tiazolilpiperidina como fungicidas
GEP20125712B (en) Method for preparation of piperazine compounds and hydrochloride salts thereof
BRPI0921593B8 (pt) processo para preparar compostos de 4-[2-(2-fluorofenoximetil)fenil]piperidina e compostos relacionados
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/04/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO